All Type of News
Whan In Pharm signs exclusive agreement of introducing the epilepsy treatment ‘Zebinix’
Whan In Pharm(CEO Won-Bum Lee) signed an exclusive license agreement of ‘Zebinix,’ an epilepsy treatment developed by Portuguese Bial(CEO António Portela), in Korea at the headquarters on the 26th.
‘Zebinix,’ a once-...
Sam Chun Dang Pharm to sign eye drop export agreements of more than KRW 1 trillion in U.S. and Europe
Sam Chun Dang Pharm has drawn attention of the industry as signing export agreements of its eye drops to advanced markets, like the U.S. and Europe. There are three reasons why this is.
According to Sam Chun Dang Pha...
Government to strengthen monitoring system on top sale biologics
In order to create a base to safely use biologics, collection and inspection of products in market will get stricter.
The Ministry of Food and Drug Safety said they would focus on securing the national relief over bi...
Who will lead KPBMA’s ethical management to eradicate illegal rebates?
The ‘National Industry Power Strengthening’ process that the former Chair Heng-Myung Lee and Chairman Hee-Mok Won have carried out will continue while Jung-Hee Lee, Chair of the Korea Pharmaceutical and Bio-Pharma Ass...
1 of 3 medicines approved as incrementally modified drug were ‘antihypertensive’
It was analyzed total 93 products have been approved as incrementally modified drug since the adoption of the incrementally modified drug system in 2009, and 1 of the 3 incrementally modified drugs were antihypertensi...
Hanmi Pharm awarded ‘BPW Gold Award’ for first time as pharma
Hanmi Pharm(CEO Jong-Su Woo, Sae-Chang Kwon) has been awarded the 24th ‘BPW Gold Award’ by the Business & Professional Women Korea(BPW Korea) for the first time as a Korean pharmaceutical company.
The award establish...
Products like ‘Repatha Inj’ & ‘Soolantra Cream 1%’ enter Asan Medical Center
Amgen’s ‘Repatha Inj’ and Galderma’s ‘Soolantra Cream 1%’ entered Asan Medical Center.
At the 142nd Drug Committee, Asan Medical Center approved introduction of ‘Repatha Inj,’ the Amgen Korea’s PCSK9-inhibiting chole...
Dong Wha Pharm’s ‘Zabolante’ and Ildong’s ‘Besivo’ selected New Drug Development Awards
The Korea Drug Research Association(Chairman Dong-Yeon Kim, KDRA) will hold the ‘19th Korea New Drug Development Awards’ at the Geranium Hall of Hotel Samjung on 27 February, 3pm.
The companies which will receive the...
Pharmaceutical inspection on GMP facilities to change to inspection focusing on risk
The pharmaceutical inspection which has been conducted on pharmaceutical companies’ GMP facilities will now focus on the level of risk.
The Ministry of Food and Drug Safety(MFDS) announced to change the pharmaceutica...
161 products including ‘Arnuity’ & ‘Abcertin’ newly registered for NHIS
161 products including ‘Arnuity,’ an asthma therapy, and ‘Abcertin,’ a Gaucher disease treatment, were newly registered in the National Health Insurance Service(NHIS).
The Ministry of Health and Welfare(MOHW) revised...
